EGFR and neoplasm: In the current study, we performed a retrospective study with propensity score matching (PSM) analysis to overcome selection bias, increase the evidence level, and investigate the implementation of tumor resection in routine clinical practice for patients with EGFR mutations and advanced NSCLC treated with EGFR TKI.